Urinary markers of altered collagen metabolism in fibromyalgia patients

Scandinavian Journal of Rheumatology

Volumn 36, Issue 6, 2007, Pages 470-477

  Ribel Madsen, S ^a   Christgau, S ^b   Gronemann, S T ^a   Bartels, E M ^c   Danneskiold Samsoe B ^a   Bliddal, H ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b NORDIC BIOSCIENCE A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 2; CREATININE; DEOXYPYRIDINOLINE; HYDROXYPROLINE; PYRIDINOLINE;

ADULT; ANALYTIC METHOD; ANXIETY DISORDER; ARTICLE; BONE DENSITY; COLLAGEN METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; KIDNEY CONCENTRATING CAPACITY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MUSCLE STRENGTH; PRIORITY JOURNAL; SPECTROPHOTOMETRY; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; CHROMATOGRAPHY, LIQUID; COLLAGEN TYPE I; COLLAGEN TYPE II; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; HUMANS; PEPTIDES; PROGNOSIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY;

EID: 37349128489     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701483048     Document Type: Article

References (32)

1. Sprott H, Muller A, Heine H. Collagen crosslinks in fibromyalgia. Arthritis Rheum 1997;40:314-7.
2. Appelboom T, Schoutens A. High bone turnover in fibromyalgia. Calcif Tissue Int 1990;46:314-7.
3. Jacobsen S, Gam A, Egsmose C, Olsen M, Danneskiold-Samsoe B, Jensen GF. Bone mass and turnover in fibromyalgia. J Rheumatol 1993;20:856-9.
4. Jacobsen S, Jensen LT, Foldager M, Danneskiold-Samsoe B. Primary fibromyalgia: clinical parameters in relation to serum procollagen type III aminoterminal peptide. Br J Rheumatol 1990;29:174-7.
5. Gronemann ST, Ribel-Madsen S, Bartels EM, Danneskiold-Samsoe B, Bliddal H. Collagen and muscle pathology in fibromyalgia patients. Rheumatology (Oxford) 2004;43:27-31.
6. Ribel-Madsen S, Gronemann ST, Bartels EM, Danneskiold-Samsoe B, Bliddal H. Collagen structure in skin from fibromyalgia patients. Int J Tissue React 2005;27:75-82.
7. Mense S. [Neurobiological basis of muscle pain] Schmerz 1999;13:3-17. German.
8. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
9. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-33.
10. Cloos PAC, Fledelius C, Christgau S, Christiansen C, Engsig M, Delmas P, et al. Investigation of bone disease using isomerized and racemized fragments of type I collagen. Calcif Tissue Int 2003;72:8-17.
11. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15.
12. Mouritzen U, Christgau S, Lehmann HJ, Tanko LB, Christiansen C. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis 2003;62:332-6.
13. Colwell A, Russell RGG, Eastell R. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 1993;23:341-9.
14. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967;19:249-55.
15. Mazess RB, Barden H, Ettinger M, Schultz E. Bone density of the radius, spine, and proximal femur in osteoporosis. J Bone Miner Res 1988;3:13-8.
16. Kaminsky, Leonard A, ed, American College of Sports Medicine; ACMSs Guidelines for Exercise Testing and Prescription, 5th edition. Baltimore: Lippincott Williams & Wilkins 1995.
17. Reginster JY, Henrotin Y, Christiansen C, Gamwell-Henriksen E, Bruyere O, Collette J, et al. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcif Tissue Int 2001;69:130-7.
18. Müller A, Jakob K, Hein GE. Evaluation of free and peptide bound collagen crosslink excretion in different skeletal diseases. Ann Rheum Dis 2003;62:65-7.
19. Bernardi D, Zaninotto M, Plebani M. Requirements for improving quality in the measurement of bone markers. Clin Chim Acta 2004;346:79-86.
20. Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum 2002;46:21-30.
21. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 2003;62:939-43.
22. Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 2004;71:70-6.
23. Christgau S, Bitsch-Jensen O, Bjarnason NH, Henriksen EG, Qvist P, Alexandersen P, Henriksen DB. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 2000;26:505-11.
24. Rovetta G, Monteforte P, Grignolo MC, Brignone A, Buffrini L. Hematic levels of type I collagen C-telopeptide in erosive versus nonerosive osteoarthritis of the hands. Int J Tissue React 2003;25:25-8.
25. Eyre D. New biomarkers of bone resorption. J Clin Endocrinol Metab 1992;74:470A-C.
26. Takahashi M, Hoshino H, Kushida K, Inoue T. Direct measurement of crosslinks, pyridinoline, deoxypyridinoline, and pentosidine, in the hydrolysate of tissues using high-performance liquid chromatography. Anal Biochem 1995;232:158-62.
27. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP. Urinary hydroxypyridinium crosslinks of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992;74:481-6.
28. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ. Changes in markers of bone formation and resorption in a bed rest model of weightlessness. J Bone Miner Res 1993;8:1433-8.
29. Seibel MJ, Duncan A, Robins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989;16:964-70.
30. Sinigaglia L, Varenna M, Binelli L, Bartucci F, Arrigoni M, Ferrara R, et al. Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995;54:144-7.
31. Rüster M, Franke S, Späth M, Pongratz DE, Stein G, Hein GE. Detection of elevated N epsilon-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia. Scand J Rheumatol 2005;34:460-3.
32. Borderie D, Roux C, Toussaint B, Dougados M, Ekindjian OG, Cherruau B. Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice. Clin Biochem 2001;34:571-7.